Funding Details
- Awarder
- Inbox
- Date Award
- November 05, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
-
$115,000,000
Company Info
- Company Description
- Evommune is a clinical-stage biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases.
- Market
- Immune-mediated inflammatory diseases
- Location
-
Palo Alto,
California,
USA
- Coinvestors
- RA Capital Management, Sectoral Asset Management, B Capital, Marshall Wace, Avego Bioscience Capital, Longwood Fund, RTW Investments, ADAR1 Capital Management, NEXTBio Capital, Beiersdorf Venture Capital, FemHealth Ventures, Allostery Investments LP, Pivotal bioVenture Partners, EQT Life Sciences, Andera Partners, Amplitude Ventures, SymBiosis, Verition Fund Management
Links